Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer

BACKGROUND: Platinum-based concurrent chemoradiotherapy (CCRT) is the primary treatment for locally advanced cervical cancer (LACC). Improving the efficacy of LACC treatment is the focus of clinical research, and nimotuzumab combined with CCRT is a new research direction. This retrospective study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Jiang, Yuqi, Jiang, Peng, Chen, Zhiying, Cui, Huanliang, Zhang, Yongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843379/
https://www.ncbi.nlm.nih.gov/pubmed/36660627
http://dx.doi.org/10.21037/atm-22-5739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843379/
https://www.ncbi.nlm.nih.gov/pubmed/36660627
http://dx.doi.org/10.21037/atm-22-5739

Ejemplares similares